ArticleVaccine2012

CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.

Matthew W Auten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.